8 results on '"Mann, Kenneth G."'
Search Results
2. Prothrombin activation by platelet-associated prothrombinase proceeds through the prethrombin-2 pathway via a concerted mechanism.
- Author
-
Haynes LM, Bouchard BA, Tracy PB, and Mann KG
- Subjects
- Anticoagulants pharmacology, Blood Coagulation, Blood Platelets metabolism, Catalysis, Collagen chemistry, Enzyme Precursors chemistry, Factor Xa chemistry, Humans, Lipid Bilayers chemistry, Microscopy, Confocal methods, Models, Biological, Phospholipids chemistry, Prothrombin chemistry, Thrombin chemistry, Time Factors, Prothrombin metabolism
- Abstract
The protease α-thrombin is a key enzyme of the coagulation process as it is at the cross-roads of both the pro- and anti-coagulant pathways. The main source of α-thrombin in vivo is the activation of prothrombin by the prothrombinase complex assembled on either an activated cell membrane or cell fragment, the most relevant of which is the activated platelet surface. When prothrombinase is assembled on synthetic phospholipid vesicles, prothrombin activation proceeds with an initial cleavage at Arg-320 yielding the catalytically active, yet effectively anticoagulant intermediate meizothrombin, which is released from the enzyme complex ∼30-40% of the time. Prothrombinase assembled on the surface of activated platelets has been shown to proceed through the inactive intermediate prethrombin-2 via an initial cleavage at Arg-271 followed by cleavage at Arg-320. The current work tests whether or not platelet-associated prothrombinase proceeds via a concerted mechanism through a study of prothrombinase assembly and function on collagen-adhered, thrombin-activated, washed human platelets in a flow chamber. Prothrombinase assembly was demonstrated through visualization of bound factor Xa by confocal microscopy using a fluorophore-labeled anti-factor Xa antibody, which demonstrated the presence of distinct platelet subpopulations capable of binding factor Xa. When prothrombin activation was monitored at a typical venous shear rate over preassembled platelet-associated prothrombinase neither potential intermediate, meizothrombin or prethrombin-2, was observed in the effluent. Collectively, these findings suggest that platelet-associated prothrombinase activates prothrombin via an efficient concerted mechanism in which neither intermediate is released.
- Published
- 2012
- Full Text
- View/download PDF
3. Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation.
- Author
-
Whelihan MF, Zachary V, Orfeo T, and Mann KG
- Subjects
- Cell Separation, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Humans, Signal Transduction physiology, Thrombin metabolism, Blood Coagulation physiology, Enzyme Precursors metabolism, Erythrocytes metabolism, Prothrombin metabolism, Thrombin biosynthesis
- Abstract
Prothrombin activation can proceed through the intermediates meizothrombin or prethrombin-2. To assess the contributions that these 2 intermediates make to prothrombin activation in tissue factor (Tf)-activated blood, immunoassays were developed that measure the meizothrombin antithrombin (mTAT) and α-thrombin antithrombin (αTAT) complexes. We determined that Tf-activated blood produced both αTAT and mTAT. The presence of mTAT suggested that nonplatelet surfaces were contributing to approximately 35% of prothrombin activation. Corn trypsin inhibitor-treated blood was fractionated to yield red blood cells (RBCs), platelet-rich plasma (PRP), platelet-poor plasma (PPP), and buffy coat. Compared with blood, PRP reconstituted with PPP to a physiologic platelet concentration showed a 2-fold prolongation in the initiation phase and a marked decrease in the rate and extent of αTAT formation. Only the addition of RBCs to PRP was capable of normalizing αTAT generation. FACS on glycophorin A-positive cells showed that approximately 0.6% of the RBC population expresses phosphatidylserine and binds prothrombinase (FITC Xa·factor Va). These data indicate that RBCs participate in thrombin generation in Tf-activated blood, producing a membrane that supports prothrombin activation through the meizothrombin pathway.
- Published
- 2012
- Full Text
- View/download PDF
4. The prothrombotic phenotypes in familial protein C deficiency are differentiated by computational modeling of thrombin generation.
- Author
-
Brummel-Ziedins KE, Orfeo T, Callas PW, Gissel M, Mann KG, and Bovill EG
- Subjects
- Area Under Curve, Blood Coagulation Tests, Computer Simulation, Female, Homozygote, Humans, Male, Models, Biological, Models, Theoretical, Phenotype, Polymorphism, Genetic, Sex Factors, Thrombosis blood, Thrombosis genetics, Protein C Deficiency blood, Protein C Deficiency genetics, Prothrombin metabolism, Thrombin metabolism
- Abstract
The underlying cause of thrombosis in a large protein C (PC) deficient Vermont kindred appears to be multicausal and not explained by PC deficiency alone. We evaluated the contribution of coagulation factors to thrombin generation in this population utilizing a mathematical model that incorporates a mechanistic description of the PC pathway. Thrombin generation profiles for each individual were generated with and without the contribution of the PC pathway. Parameters that describe thrombin generation: maximum level (MaxL) and rate (MaxR), their respective times (TMaxL, TMaxR), area under the curve (AUC) and clotting time (CT) were examined in individuals ± PC mutation, ± prothrombin G20210A polymorphism and ± thrombosis history (DVT or PE). This family (n = 364) is shifted towards greater thrombin generation relative to the mean physiologic control. When this family was analyzed with the PC pathway, our results showed that: carriers of the PC mutation (n = 81) had higher MaxL and MaxR and greater AUC (all p<0.001) than non-carriers (n = 283); and individuals with a DVT and/or PE history (n = 13) had higher MaxL (p = 0.005) and greater AUC (p<0.001) than individuals without a thrombosis history (n = 351). These differences were further stratified by gender, with women in all categories generating more thrombin than males. These results show that all individuals within this family with or without PC deficiency have an increased baseline procoagulant potential reflective of increased thrombin generation. In addition, variations within the plasma composition of each individual can further segregate out increased procoagulant phenotypes, with gender-associated plasma compositional differences playing a large role.
- Published
- 2012
- Full Text
- View/download PDF
5. Dilutional control of prothrombin activation at physiologically relevant shear rates.
- Author
-
Haynes LM, Dubief YC, Orfeo T, and Mann KG
- Subjects
- Animals, Cattle, Enzyme Activation, Enzyme Precursors metabolism, Hemorheology, Humans, Kinetics, Models, Biological, Protein Structure, Tertiary, Prothrombin chemistry, Thrombin metabolism, Thromboplastin metabolism, Prothrombin metabolism, Stress, Mechanical
- Abstract
The generation of proteolyzed prothrombin species by preassembled prothrombinase in phospholipid-coated glass capillaries was studied at physiologic shear rates (100-1000 s(-1)). The concentration of active thrombin species (α-thrombin and meizothrombin) reaches a steady state, which varies inversely with shear rate. When corrected for shear rate, steady-state levels of active thrombin species exhibit no variation and a Michaelis-Menten analysis reveals that chemistry of this reaction is invariant between open and closed systems; collectively, these data imply that variations with shear rate arise from dilutional effects. Significantly, the major products observed include nonreactive species arising from the loss of prothrombin's phospholipid binding domain (des F1 species). A numerical model developed to investigate the spatial and temporal distribution of active thrombin species within the capillary reasonably approximates the observed output of total thrombin species at different shears; it also predicts concentrations of active thrombin species in the wall region sufficient to account for observed levels of des FI species. The predominant feedback formation of nonreactive species and high levels of the primarily anticoagulant intermediate meizothrombin (∼40% of total active thrombin species) may provide a mechanism to prevent thrombus propagation downstream of a site of thrombosis or hemorrhage., (Copyright © 2011 Biophysical Society. Published by Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
6. From Principle to Practice: Bridging the Gap in Patient Profiling.
- Author
-
Foley, Jonathan H., Orfeo, Thomas, Undas, Anetta, McLean, Kelley C., Bernstein, Ira M., Rivard, Georges-Etienne, Mann, Kenneth G., Everse, Stephen J., Brummel-Ziedins, Kathleen E., and Cate, Hugo ten
- Subjects
BLOOD coagulation factors ,BLOOD coagulation ,PARTIAL thromboplastin time ,PROTHROMBIN ,BLOOD proteins ,HEMORRHAGE - Abstract
The standard clinical coagulation assays, activated partial thromboplastin time (aPTT) and prothrombin time (PT) cannot predict thrombotic or bleeding risk. Since thrombin generation is central to haemorrhage control and when unregulated, is the likely cause of thrombosis, thrombin generation assays (TGA) have gained acceptance as "global assays" of haemostasis. These assays generate an enormous amount of data including four key thrombin parameters (lag time, maximum rate, peak and total thrombin) that may change to varying degrees over time in longitudinal studies. Currently, each thrombin parameter is averaged and presented individually in a table, bar graph or box plot; no method exists to visualize comprehensive thrombin generation data over time. To address this need, we have created a method that visualizes all four thrombin parameters simultaneously and can be animated to evaluate how thrombin generation changes over time. This method uses all thrombin parameters to intrinsically rank individuals based on their haemostatic status. The thrombin generation parameters can be derived empirically using TGA or simulated using computational models (CM). To establish the utility and diverse applicability of our method we demonstrate how warfarin therapy (CM), factor VIII prophylaxis for haemophilia A (CM), and pregnancy (TGA) affects thrombin generation over time. The method is especially suited to evaluate an individual's thrombotic and bleeding risk during "normal" processes (e.g pregnancy or aging) or during therapeutic challenges to the haemostatic system. Ultimately, our method is designed to visualize individualized patient profiles which are becoming evermore important as personalized medicine strategies become routine clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
7. Membrane Binding Events in the Initiation and Propagation Phases of Tissue Factor-initiated Zymogen Activation under Flow.
- Author
-
Haynes, Laura M., Dubief, Yves C., and Mann, Kenneth G.
- Subjects
- *
ZYMOGENS , *CELL membranes , *PROTHROMBIN , *DIFFUSION , *BLOOD proteins , *BLOOD vessels - Abstract
This study investigates the dynamics of zymogen activation when both extrinsic tenase and prothrombinase are assembled on an appropriate membrane. Although the activation of prothrombin by surface-localized prothrombinase is clearly mediated by flow-induced dilutional effects, we find that when factor X is activated in isolation by surface-localized extrinsic tenase, it exhibits characteristics of diffusion-mediated activation in which diffusion of substrate to the catalytically active region is rate-limiting. When prothrombin and factor X are activated coincident with each other, competition for available membrane binding sites masks the diffusion-limiting effects of factor X activation. To verify the role of membrane binding in the activation of factor X by extrinsic tenase under flow conditions, we demonstrate that bovine lactadherin competes for both factor X and Xa binding sites, limiting factor X activation and forcing the release of bound factor Xa from the membrane at a venous shear rate (100 s-1). Finally, we present steady-state models of prothrombin and factor X activation under flow showing that zymogen and enzyme membrane binding events further regulate the coagulation process in an open system representative of the vasculature geometry. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
8. Structural Requirements for Expression of Factor Va Activity.
- Author
-
Kalafatis, Michael, Beck, Daniel O., and Mann, Kenneth G.
- Subjects
- *
HEMOSTASIS , *ENZYMES , *THROMBIN , *PROTHROMBIN - Abstract
Thrombin activated factor Va (factor V[sub IIa], residues 1-709 and 1546-2196) has an apparent dissociation constant (K[sub d,app]) for factor Xa within prothrombinase of ∼0.5 nM. A protease (NN) purified from the venom of the snake Naja nigricollis nigricollis, cleaves human factor V at Asp[sup 697], Asp[sup 1509], and Asp[sup 1514] to produce a molecule (factor V[sub NN]) that is composed of a M[sub r] 100,000 heavy chain (amino acid residues 1-696) and a M[sub r] 80,000 light chain (amino acid residues 1509/1514-2196). Factor V[sub NN], has a K[sub d,app] for factor Xa of 4 nM and reduced clotting activity. Cleavage of factor V[sub IIa] by NN at Asp[sup 697] results in a cofactor that loses ∼60-80% of its clotting activity. An enzyme from Russell's viper venom (RVV) cleaves human factor V at Arg[sup 1018] and Arg[sup 1545] to produce a M[sub r] 150,000 heavy chain and M[sub r] 74,000 light chain (factor V[sub RVV], residues 1-1018 and 1546-2196). The RVV species has affinity for factor Xa and clotting activity similar to the thrombin-activated factor Va. Cleavage of factor V[sub NN] at Arg[sup 1545] by α-thrombin (factor V[sub NN/IIa]) or RVV (factor V[sub NN/RVV]) leads to enhanced affinity of the cofactor for factor Xa (K[sub d,app] ∼ 0.5 nM). A synthetic peptide containing the last 13 residues from the heavy chain of factor Va (amino acid sequence 697-709, D13R) was found to be a competitive inhibitor of prothrombinase with respect to prothrombin. The peptide was also found to specifically interact with thrombin-agarose. These data demonstrate that 1) cleavage at Arg[sup 1545] and formation of the light chain of factor V[sub IIa] is essential for high affinity binding and function of factor Xa within prothrombinase and 2) a binding site for prothrombin is contributed by amino acid residues 697-709 of the heavy chain of the cofactor. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.